<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Algorithm for selection of children for antiviral treatment of chronic HBV</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Algorithm for selection of children for antiviral treatment of chronic HBV</h1>
<div class="graphic"><div class="figure"><div class="ttl">Algorithm for selection of children for antiviral treatment of chronic HBV</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_footnotes">HBV: hepatitis B virus; HBsAg: hepatitis B s antigen; ALT: alanine aminotransferase; ULN: upper limit of normal; HBeAg: hepatitis B e antigen; DNA: deoxyribonucleic acid; IU: international unit; AST: aspartate aminotransferase.<br/>* Here, "persistent" means for at least four months. The upper limit of normal (ULN) for ALT in children is not well-established; it varies with the testing laboratory and the age of the child. For the purposes of making treatment decisions about chronic hepatitis B, a consensus guidance suggests using an ALT threshold of &lt;25 U/L for girls, &lt;35 U//L for boys, for consistency with recommendations in adults.<sup>[1]</sup> ALT values should also be interpreted in the context of the patient's prior ALT results.<br/>¶ Patients with normal ALT and intermediate HBV DNA concentrations (HBV DNA 2000-20,000 IU/mL) cannot be immediately categorized; suggest retesting in a few months.<br/>Δ For the rare patient who has persistently elevated ALT but has low viral load (HBV DNA &lt;2000 IU/mL), an evaluation for additional causes of liver disease is appropriate.<br/><font class="lozenge">◊</font> For patients in the immune tolerant and inactive chronic HBV phases, we suggest monitoring liver biochemical tests (ALT and AST) every 6 to 12 months, and HBeAg and HBeAb every 12 months. If the ALT becomes elevated, HBV DNA should be measured.<br/>§ Treatment is indicated for most patients in the immune active, HBeAg positive phase. However, if the liver biopsy shows little or no inflammation or fibrosis, it is reasonable to defer treatment with ongoing monitoring.</div><div class="graphic_reference">Reference:

<ol>
<li>Terrault NA, Lok ASF, McMahon BJ, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology 2018; 67:1560.</li>
</ol>

Modified from: Jonas MM, Block JM, Haber BA, et al. Treatment of children with chronic hepatitis B virus infection in the United States: Patient selection and therapeutic options. Hepatology 2010. Copyright © 2010 American Association for the Study of Liver Diseases. Adapted with permission from John Wiley &amp; Sons.</div><div id="graphicVersion">Graphic 78464 Version 8.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
